• Cheng A*, Kawahata I, Wang Y, Jia W, Wang H, Sekimori T, Chen Y, Suzuki H, Takeda A, Stefanova N, , Ma W, Chen M, Finkelstein D, Sasaki T*, Fukunaga K*.

Epsin2, a novel target for multiple system atrophy therapy via regulating α-synuclein propagation associated with FABP7.

Brain (2023) 146(8): 3172–3180.

• Cheng A^+, *, Jia W⁺, Finkelstein D, Stefanova N, Wang H, Sasaki T, Kawahata I, Fukunaga K*.

FABP7 inhibition for cerebellum ataxia: a pharmacological study in multiple system atrophy model mouse.

Acta Pharmacologica Sinica (2024) 45 (1): 66-75.

• Cheng A, Jia W, Kawahata I, Fukunaga K*.

A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse model.

eBioMedicine (2021) 72: 103582.

• Cheng A, Wang Y, Shinoda Y, Kawahata I, Yamamoto T, Jia W, Yamamoto H, Mizobata T, Kawata Y, Fukunaga K*.

Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress.

Acta Pharmacologica Sinica (2022) 43(3): 552-562.